Search Ontology:
ChEBI

alpha-D-GalpNAc-(1->3)-beta-D-Galp-(1->4)-alpha-D-Glcp

Term ID
CHEBI:149247
Synonyms
  • 2-acetamido-2-deoxy-alpha-D-galacto-hexopyranosyl-(1->3)-beta-D-galacto-hexopyranosyl-(1->4)-alpha-D-gluco-hexopyranose
  • 2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-alpha-D-glucopyranose
  • GalNAc(a1-3)Gal(b1-4)a-Glc
  • N-[(2R,3R,4R,5R,6R)-2-[(2R,3S,4S,5R,6S)-3,5-Dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
Definition
An amino trisaccharide consisting of 2-acetamido-2-deoxy-α-D-galactopyranose, β-D-galactopyranose and α-D-glucopyranose residues joined in sequence by (1→3) and (1→4) glycosidic bonds.
References
  • glygen:G32215KN
  • glytoucan:G32215KN
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from alpha-D-GalpNAc-(1->3)-beta-D-Galp-(1->4)-alpha-D-Glcp
Phenotype where environments contain alpha-D-GalpNAc-(1->3)-beta-D-Galp-(1->4)-alpha-D-Glcp
Phenotype modified by environments containing alpha-D-GalpNAc-(1->3)-beta-D-Galp-(1->4)-alpha-D-Glcp
Phenotype affecting alpha-D-GalpNAc-(1->3)-beta-D-Galp-(1->4)-alpha-D-Glcp
Human Disease Model